SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-16-000311
Filing Date
2016-11-01
Accepted
2016-11-01 08:16:20
Documents
10
Period of Report
2016-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nlnk-20161101x8k.htm 8-K 28027
2 PRESS RELEASE nlnk-20161101x8kxex991.htm EX-99.1 122838
3 SLIDES nlnkq32016slides.htm EX-99.2 7935
4 LOGO newlogoa11.jpg GRAPHIC 14001
5 nlnkq32016slides001.jpg GRAPHIC 138436
6 nlnkq32016slides002.jpg GRAPHIC 189682
7 nlnkq32016slides003.jpg GRAPHIC 119095
8 nlnkq32016slides004.jpg GRAPHIC 72893
9 nlnkq32016slides005.jpg GRAPHIC 109020
10 nlnkq32016slides006.jpg GRAPHIC 66128
  Complete submission text file 0001126234-16-000311.txt   1137608
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 161963308
SIC: 2834 Pharmaceutical Preparations